Viewing Study NCT00399269


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-01-05 @ 5:23 AM
Study NCT ID: NCT00399269
Status: COMPLETED
Last Update Posted: 2009-06-11
First Post: 2006-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
Sponsor: Cadila Pharnmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-12
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2007-06
Completion Date Type: ACTUAL
First Submit Date: 2006-11-12
First Submit QC Date: None
Study First Post Date: 2006-11-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-06-10
Last Update Post Date: 2009-06-11
Last Update Post Date Type: ESTIMATED